<DOC>
	<DOCNO>NCT02877784</DOCNO>
	<brief_summary>Oculopharyngeal muscular dystrophy ( OPMD ) rare myopathic disease result progressive degeneration oral pharyngeal muscular , result severe dysphagia dysarthria . OPMD consider rare disease ; therefore , limit research available natural progression disease utility biomarkers identify swallow impairment . The aim study : 1 . To identify accurate , reliable non-invasive clinical marker swallow impairment 2 . To determine discriminate ability marker identify impairment swallow safety swallow efficiency .</brief_summary>
	<brief_title>Screening Oculopharyngeal Muscular Dystrophy</brief_title>
	<detailed_description>Participants recruit Neurology clinic University Florida . The single evaluation occur PIs research laboratory University Florida , Gainesville , Florida .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Oculopharyngeal</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>diagnosis oculopharyngeal muscular dystrophy allergy barium capsaicin , tracheotomy mechanical ventilation significant concurrent respiratory disease ( e.g. , COPD ) . Pregnant Women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>screen</keyword>
	<keyword>OPMD</keyword>
	<keyword>dysphagia</keyword>
	<keyword>dysarthria</keyword>
</DOC>